AbCellera Biologics Inc. (ABCL)
NASDAQ·Healthcare·Biotechnology
$4.14
-0.60%
Mkt Cap $1.23B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | $6.67M | $44.90M | +572.89% | -$0.18 | -$0.03 | +83.33% | — | — |
| Q4 2025 Nov 6, 2025 | $6.31M | $8.96M | +41.87% | -$0.17 | -$0.19 | -11.76% | — | — |
| Q3 2025 Aug 7, 2025 | $6.36M | $17.08M | +168.63% | -$0.17 | -$0.12 | +29.41% | — | — |
| Q2 2025 May 8, 2025 | $7.31M | $4.24M | -42.06% | -$0.17 | -$0.15 | +11.76% | — | — |
| Q1 2025 Feb 27, 2025 | $7.58M | $5.05M | -33.37% | -$0.15 | -$0.11 | +26.67% | — | — |
| Q4 2024 Nov 4, 2024 | $7.58M | $6.51M | -14.15% | -$0.14 | -$0.17 | -21.43% | — | — |
| Q3 2024 Aug 6, 2024 | $10.15M | $7.32M | -27.85% | -$0.15 | -$0.13 | +13.33% | — | — |
| Q2 2024 May 7, 2024 | $11.02M | $9.95M | -9.67% | -$0.16 | -$0.14 | +12.50% | — | — |
| Q1 2024 Feb 20, 2024 | $8.88M | $9.18M | +3.37% | -$0.14 | -$0.17 | -21.43% | — | — |
| Q4 2023 Nov 2, 2023 | $11.90M | $6.60M | -44.55% | -$0.14 | -$0.10 | +28.57% | — | — |
| Q3 2023 Aug 3, 2023 | $12.46M | $10.06M | -19.29% | -$0.13 | -$0.11 | +15.38% | — | — |
| Q2 2023 May 4, 2023 | $12.11M | $12.19M | +0.68% | -$0.12 | -$0.14 | -16.67% | — | — |
| Q1 2023 Feb 21, 2023 | $50.80M | $485.42M | +855.54% | -$0.01 | -$0.10 | -1804.76% | — | — |
| Q4 2022 Nov 8, 2022 | $74.96M | $101.38M | +35.25% | $0.05 | $0.08 | +60.00% | — | — |
| Q3 2022 Aug 9, 2022 | $53.59M | $45.92M | -14.32% | -$0.02 | -$0.02 | -28.45% | — | — |
| Q2 2022 May 10, 2022 | $219.75M | $316.58M | +44.06% | $0.38 | $0.54 | +42.11% | — | — |
| Q1 2022 Feb 24, 2022 | $122.05M | $139.33M | +14.16% | $0.19 | $0.19 | +0.00% | — | — |
| Q4 2021 Nov 9, 2021 | $16.20M | $5.51M | -66.00% | -$0.05 | -$0.08 | -60.00% | — | — |
| Q3 2021 Aug 12, 2021 | $27.64M | $27.64M | +0.00% | $0.09 | -$0.01 | -111.11% | — | — |
| Q2 2021 May 13, 2021 | $208.08M | $202.74M | -2.56% | $0.38 | $0.37 | -2.63% | — | — |